Aerie Pharmaceuticals, Inc. (AERI) Social Stream
AERIE PHARMACEUTICALS INC (AERI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AERI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $30 | $9 | $24.555 | $15.23 | 61.23% |
| 2022-01-13 | 9 | $30 | $9 | $24.125 | $15.23 | 58.4% |
| 2022-01-27 | 9 | $30 | $9 | $23.375 | $15.23 | 53.48% |
| 2022-02-25 | 9 | $30 | $9 | $22.75 | $15.23 | 49.38% |
| 2022-02-28 | 9 | $30 | $7 | $21.875 | $15.23 | 43.63% |
| 2022-05-06 | 9 | $30 | $7 | $21.375 | $15.23 | 40.35% |
| 2022-05-09 | 9 | $30 | $6 | $21.25 | $15.23 | 39.53% |
| 2022-05-23 | 9 | $30 | $6 | $20.625 | $15.23 | 35.42% |
| 2022-08-08 | 9 | $30 | $6 | $20.375 | $15.23 | 33.78% |
| 2022-08-13 | 8 | $30 | $6 | $20.375 | $15.23 | 33.78% |
| 2022-08-19 | 9 | $30 | $6 | $20.5 | $15.23 | 34.6% |
| 2022-08-23 | 8 | $25 | $6 | $16.642 | $15.23 | 9.27% |
| 2022-08-24 | 8 | $25 | $6 | $16.285 | $15.23 | 6.93% |
| 2022-08-29 | 9 | $25 | $6 | $16.156 | $15.23 | 6.08% |
The Trend in the Analyst Price Target
AERI's average price target has moved down $12.13 over the prior 13 months.
Over the past 33 weeks, AERI's average upside potential has been 148.3%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 9 | 30 | 9 | 24.125 | 7.46 | 223.39% |
| 2022-05-06 | 9 | 30 | 7 | 21.375 | 6.25 | 242% |
| 2022-08-24 | 8 | 25 | 6 | 16.285 | 15.18 | 7.28% |
| 2022-08-29 | 9 | 25 | 6 | 16.156 | 15.07 | 7.21% |
| 2022-08-29 | 9 | 25 | 6 | 15.321 | 15.07 | 1.67% |
AERI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.89 | 1 | 0 | 7 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
AERI's average broker recommendation rating worsened by 0.12 over the prior 43 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AERI as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, AERIE PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1414.6% of them.
- In terms of how AERIE PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 327.9% of that group.
- In terms of how AERIE PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 438.57% of that group.
- In the context of Pharmaceutical Products stocks, AERIE PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1229.71% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AERIE PHARMACEUTICALS INC are SGMO, VCEL, and BCRX.
View All Top Stocks by Price Target
What is the outlook for AERI? Use POWR Ratings for clearer insight into price direction.